top of page
Report Summary
Market Overview

Global Blood Testing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Blood Testing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Type (Glucose Testing, Lipid Panel Testing, Prostate Specific Antigen (PSA) Testing, Blood Urea Nitrogen (BUN) Testing, Thyroid Stimulating Hormone Testing, and Other Types), Methods (Manual Blood Testing, and Automated Blood Testing), End User (Diagnostic Laboratories, Hospitals, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)


Market Overview


The Global Blood Testing Market was valued at USD 99,448.0 million in 2023 and is expected to reach USD 182,712.2 million by 2031 while growing at a CAGR of 7.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global blood testing market growth.  Blood testing, which involves analyzing blood samples in a laboratory, serves to assess different aspects of an individual's health and diagnose medical conditions. It is among the most prevalent diagnostic techniques in healthcare, offering crucial insights into a patient's general health, organ functionality, nutrient levels, infection presence, and potential risk factors for diseases.


The growing prevalence of chronic diseases like diabetes, cardiovascular disorders, and cancer, coupled with a heightened focus on preventive healthcare, propels the blood testing market forward. Nonetheless, challenges such as reimbursement issues and cost constraints could hinder its growth.


Furthermore, the global blood testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Type Analysis


The Global Blood Testing Market is segmented among Glucose Testing, Lipid Panel Testing, Prostate Specific Antigen (PSA) Testing, Blood Urea Nitrogen (BUN) Testing, Thyroid Stimulating Hormone Testing, and Other Types, based on Type. In 2023, Glucose Testing accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Methods Analysis


The Global Blood Testing Market is segmented among Manual Blood Testing, and Automated Blood Testing, based on Methods. In 2023, Manual Blood Testing accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Blood Testing Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, BioRad Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, Novartis International AG, Thermo Fisher Scientific, Una Health Ltd, and Shimadzu Corporation.


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Blood Testing Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Blood Testing Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Blood Testing Market Segmentation, By Type

  • Global Blood Testing Market Share Analysis, By Type

  • Global Blood Testing Market Growth Analysis, By Type

  • Global Blood Testing Market Trends, By Type

o Glucose Testing

o Lipid Panel Testing

o Prostate Specific Antigen (PSA) Testing

o Blood Urea Nitrogen (BUN) Testing

o Thyroid Stimulating Hormone Testing

o Other Types (Direct LDL testing, Testosterone Testing)

6. Global Blood Testing Market Segmentation, By Methods

  • Global Blood Testing Market Share Analysis, By Methods

  • Global Blood Testing Market Growth Analysis, By Methods

  • Global Blood Testing Market Trends, By Methods

o Manual Blood Testing

o Automated Blood Testing

7. Global Blood Testing Market Segmentation, By End User

  • Global Blood Testing Market Share Analysis, By End User

  • Global Blood Testing Market Growth Analysis, By End User

  • Global Blood Testing Market Trends, By End User

o Diagnostic Laboratories

o Hospitals

o Other End Users

8. Global Blood Testing Market Segmentation, By Region

  • Global Blood Testing Market Share Analysis, By Region

  • Global Blood Testing Market Growth Analysis, By Region

  • Global Blood Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

  • Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Becton, Dickinson and Company

  • BioMerieux SA

  • BioRad Laboratories

  • Danaher Corporation

  • F. Hoffmann-La Roche AG

  • Novartis International AG

  • Thermo Fisher Scientific

  • Una Health Ltd

  • Shimadzu Corporation

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page